Bristol receives subpoena over Abilify marketing

02/20/2012 | Wall Street Journal, The

The U.S. Attorney's Office for the Southern District of New York subpoenaed Bristol-Myers Squibb in an investigation of the company's marketing practices for antipsychotic Abilify, according to a company filing with the Securities and Exchange Commission.

View Full Article in:

Wall Street Journal, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT